Jan 31, 2025, 07:17
Catherine Alix-Panabières: Epigenomic Profiling of Liquid Biopsy and Immunotherapy Resistance in Lung Cancer
Catherine Alix-Panabières, Full Professor of Oncology at the Faculty of Medicine of the University of Montpellier, shared on LinkedIn:
“Today (30/01/2025) was the Kick-off Meeting of our European TRANSCAN project JTC 2023 called ‘EPILUNAR’!
Epigenomic Profiling of Liquid Biopsy and Immunotherapy Resistance in Lung Cancer
To identify and validate novel non-invasive epigenetic biomarkers and mechanisms of resistance associated to Immune Chekpoint Inhibitors – ICI (anti-PD1/anti-PDL1) in metastatic Non Small Cell Lung Cancer patients by characterizing the Epigenomic landscape of Liquid Biopsy, which will allow to personalize the management of Immunotherapy.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 31, 2025, 07:03
Jan 31, 2025, 06:57
Jan 31, 2025, 06:53